My research focuses on acute myeloid leukemia genetics, as well as age-associated differences in mutational landscape and prognostic significance of molecular markers. My group aims to identify prognostic factors that lead to refinements of disease classification and molecular subtypes, followed by the identification and functional characterization of coding and non-coding candidate genes. In addition, I am working on tumor genomics specific to the of adolescent and adult cancer patient population with rare malignancies.

I also serve as director of the Clara D. Bloomfield Center for Leukemia Outcomes Research at The Ohio State University, which leads AML correlative studies directed at discovering associations between patient outcomes, genetic/genomic features, and clinical/demographic characteristics. The Center is dedicated to the long-term friend and mentor of countless Leukemia researchers and clinicians, Clara Bloomfield, and was established in 2020 to carry on her legacy of molecular prognostic association studies in AML and other hematologic malignancies.